Cohort of Patients With Chronic Myelomonocytic Leukemia
This study is inviting adults diagnosed with a specific type of blood cancer called chronic myelomonocytic leukemia (CMML) to take part. Researchers will be collecting blood and other biological samples from participants over time. These samples will be taken when patients are first diagnosed, and also as their condition changes, whether they are receiving treatment or not. The samples will always be collected during routine hospital visits or as part of other clinical trials they might be involved in, so no extra appointments are needed. By studying these samples, researchers hope to gain a much clearer understanding of CMML, how it develops, and how it responds to different treatments, which could lead to better care for patients in the future.
At a glance
What is this study about?
This study is about a type of blood cancer called Chronic Myelomonocytic Leukemia, often shortened to CMML. It's a condition where the body makes too many white blood cells, specifically a type called monocytes. This study is like a detective story where researchers are gathering clues to understand CMML better.
They're doing this by collecting biological samples, like blood, from people who have been diagnosed with CMML. These samples will be taken at different times: when the person is first diagnosed, and then later as their condition evolves, whether they are having treatment or not. Importantly, these samples will always be collected during appointments or tests that are already scheduled as part of their regular care, so you won't need extra trips to the hospital just for this study.
The main goal is to build up a collection of samples and information to help medical science. By closely examining these samples, researchers hope to learn more about how CMML develops, how it changes over time, and how different treatments might affect it. This deeper understanding could be vital in developing new and more effective ways to diagnose and treat CMML in the future, ultimately improving the lives of patients.
Key takeaways
- Researchers are collecting samples to understand CMML better.
- Participation involves biological sample collection during routine care.
- No extra hospital visits or new treatments are involved.
- Your samples help medical research to improve future patient care.
- You can stop participating at any time without affecting your medical treatment.
Who may be eligible?
This study is looking for adult patients who have been diagnosed with chronic myelomonocytic leukemia (CMML). You must be 18 years old or older to take part.
You might be eligible if blood tests show you have a certain number of specific white blood cells (monocytes) or if a doctor has officially confirmed you have CMML. It doesn't matter if you're newly diagnosed, if your condition has changed, or if you're already receiving treatment – you can still be considered.
Hwever, you would not be able to join if you have a serious, uncontrolled infection (like certain types of hepatitis or HIV) or if you decide you don't want to give your permission to be involved.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with chronic myelomonocytic leukemia (CMML)?
- Are you comfortable with samples being collected during your usual hospital appointments?
- Do you not have an active, uncontrolled severe infection (like certain types of hepatitis or HIV)?
What does participation involve?
If you decide to take part, your involvement will be quite straightforward. Researchers will collect biological samples, such as blood, from you. These samples will always be taken during appointments you already have scheduled for your regular care, or as part of any other clinical trials you might be participating in. This means you won't need any extra visits to the hospital or clinic solely for this study. The study doesn't involve new medications or special treatments. Your participation would continue for an unspecified period, as samples are collected over time as part of your ongoing care.
Potential risks and benefits
Locations (24)
- CHU Amiens PicardieVerified postcodeAmiens, France· Not yet recruiting
- CHU AngersVerified postcodeAngers, France· Not yet recruiting
- Hôpital Privé AntonyVerified postcodeAntony, France· Not yet recruiting
- AP-HP Hôpital AvicenneVerified postcodeBobigny, France· Not yet recruiting
- Centre Hospitalier Sud FrancilienVerified postcodeCorbeil-Essonnes, France· Not yet recruiting
- CHU GrenobleVerified postcodeGrenoble, France· Not yet recruiting
- AP-HP Hôpital BicêtreVerified postcodeLe Kremlin-Bicêtre, France· Not yet recruiting
- CHRU Lille Hôpital Claude HuriezVerified postcodeLille, France· Not yet recruiting
- CHU LimogesVerified postcodeLimoges, France· Not yet recruiting
- CHU NantesVerified postcodeNantes, France· Not yet recruiting
- CHU Nice Hôpital l'Archet 1Verified postcodeNice, France· Not yet recruiting
- Groupe Hospitalo-Universitaire Caremeau Institut de Cancérologie du GardVerified postcodeNîmes, France· Not yet recruiting
Common questions
What kind of samples will be collected?
Mainly blood samples, but other biological samples may also be collected as part of your routine care.
Will I have extra hospital visits for this study?
No, samples will only be collected during appointments you already have for your usual medical care or other trials.
Will this study give me new medicine?
No, this study is about collecting samples and information, not testing new treatments.
What happens to my samples?
Your samples will be anonymised (meaning your name won't be attached) and used by researchers to learn more about CMML.
Can I stop being part of the study if I change my mind?
Yes, you can choose to leave the study at any time, and this will not affect your medical care.
How to find out more
Christophe WILLEKENS
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.